Dysbiosis can impair the function of the intestinal barrier to allow the passage of LPS from intestinal Gram-negative bacteria into the systemic circulation, which can stimulate Toll-like receptor 4 (TLR4)-mediated inflammation, leading to metabolic endotoxemia and insulin resistance (Plociennikowska et al., 2015). The gene discussed is TLR4; the disease is Insulin resistance.